TransCode Therapeutics (RNAZ)
NASDAQ:RNAZ
Want to see RNAZ full AI Analyst Report?
TransCode Therapeutics (RNAZ) Ownership Overview
1.53% Mutual Funds
1.28% Other Institutional Investors
0.71% ETFs
96.48% Public Companies and
Individual Investors
The ownership structure of TransCode Therapeutics (RNAZ) stock is a mix of institutional, retail, and individual investors. Approximately 3.52% of the company’s stock is owned by Institutional Investors, and 96.48% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,473 | Institution | 0.81% | 63,670 | |
| 6,545 | Institution | 0.71% | 55,763 | |
| 6,545 | Institution | 0.71% | 55,763 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,473 | Institution | 0.81% | 63,670 | |
| 6,545 | Institution | 0.71% | 55,763 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,545 | Institution | 0.71% | 56,352 |
FAQ
Who Owns TransCode Therapeutics (RNAZ)?
Currently, no data Available
What percentage of TransCode Therapeutics (RNAZ) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.28% of TransCode Therapeutics (RNAZ) stock is held by institutional investors.
What percentage of TransCode Therapeutics (RNAZ) stock is held by retail investors?
According to the latest TipRanks data, approximately 96.48% of TransCode Therapeutics (RNAZ) stock is held by retail investors.
Who owns the most shares of TransCode Therapeutics (RNAZ)?
Fidelity Concord Street Trust owns the most shares of TransCode Therapeutics (RNAZ).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.